Innovative Dabigatran Solid Dispersion Formulation
Tech ID
P27-1134
Patent Status
Granted in India
Design Status
--
Technical Description
This invention presents an advanced solid dispersion formulation of dabigatran that aims to improve pharmacokinetics and pharmacodynamics for the purpose of treating stroke disorders successfully.
Problems Addressed
- Low Oral bioavailability
- Poor water solubility
- Increased risk of bleeding
- Complexities in PEG inhibition
- Inter-individual variability challenges
- Issues with pharmacokinetic profiles
TARGET AUDIENCE
- Pharmaceutical Industry
- Research Institutions
- Healthcare Providers
- Regulatory Agencies
TECH FEATURES
- Enhanced Bioavailability
- Improved Solubility
- Stabilized Pharmacokinetics
- Reduced Bleeding Risk & Daily Dose
- Minimized Inter-individual Variability
P27-1134
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com